It’s no secret that the life sciences sector has fueled demand for Big Law firms even as the legal sector grappled with the initial shock of the pandemic. This work is particularly core to Cooley, where the life sciences sector touches a third of the firm’s $1.5 billion in annual revenue, with 95% of its attorneys serving life sciences clients.

“If you took the life sciences group out of the firm, it would be its own Am Law 100 firm,” Christian Plaza, vice chairman of the firm’s global life sciences group, said.